Bookmark Kaumudi Online  Bookmark this site  Editor@Kaumudi  |  Marketing  Print Advt rates  |  Calendar 2018        Go!    
 
 
April 25, Wednesday 2018 12:05 AM       

       HEADLINES: Nurses’ strike called off                                              Petrol, diesel prices go up again                                              Sreejith’s custody death: Family to approach HC seeking CBI probe                                              Mysterious deaths in Pinarayi: Cause of death is aluminium phosphide, mother under custody                                              I’m not VS sympathiser: Sitaram Yechury                                              POCSO Act: Death penalty will be futile, says Justice Shah                                              Siddaramaiah files nomination from Badami                                              Parliament is not immune to casting couch: Renuka Chowdhary                                              Decision to reject impeachment motion against CJI was not hasty: Venkaiah Naidu                                              Centre defends death by hanging in SC, says far safer and quicker                                              Death toll in Toronto truck collision rises to 10                                              Fire in karaoke bar in China kills at least 18                                              Selective army censorship of press may impact Pak polls                                              US plans to end work permits for spouses of H-1B visa holders                                              IPL '18: Kings XI Punjab prevail as DD continue to lose                                              I’ll share champagne with Kohli if he breaks my record: Tendulkar                                              Barcelona Open: Bopanna-Vasselin look for winning start                                              Zverer surges to 3rd spot, Nadal stays top in ATP rankings                                              Tendulkar recalls 'happy dents' of World Cup triumph                                              Kaumudi Facebook
       SCI&TECH Next Article: Here is how you can travel smart using these apps!  
       A new ray of hope for breast cancer patients!
 
         Posted on :23:35:15 Mar 22, 2018
   
A A
       Last edited on:23:35:15 Mar 22, 2018
         Tags: Three-part molecule, Breast cancer patients
 

WASHINGTON DC: A new ray of hope has been found for breast cancer patients.

A newly designed three-part molecule could be the one answer patients with a certain form of breast cancer are looking for, according to a study conducted by the Medical College of Georgia at Augusta University.

This chimera, created by a team at the Georgia Cancer Center, has the ability to simultaneously decrease the expression of three growth factors that are over-expressed in some cancers.

The growth factors are human epidermal growth factor receptor 2 (HER2), human epidermal growth factor receptor 3 (HER3), and epidermal growth factor receptor (EGFR).

The new chimera interferes with HER2 and HER3 signaling and ultimately leads to cancer cell death.

"When HER2 is expressed in a cell, you'll usually find high expression of HER3, too," said researcher Hongyan Liu.

Extensive studies have found that 20-30 percent of breast cancers are characterized by over-expression of HER2, which makes the cancer cells grow and divide faster, leading to a cancer that's more aggressive and more likely to be resistant to the standard of care.

Patients with this type of breast cancer tend to have a poorer prognosis. "As a bioengineer, I am developing the materials for cancer-targeted treatment," Liu said.

"I have experience building multifunctional chimeras to target different types of genes associated with cancer cells."

Liu and her team created their molecule to target HER family receptors EGFR, HER2, and HER3 all at once, since it is well-known that another HER family member can compensate for one that is blocked by a drug having a single target.

Each component of this tripartite molecule has potent anti-tumor activity. The molecule was designed such that the EGFR-targeting component is sandwiched between the HER2- and HER3-targeting components in what is known as a HER2 aptamer-EGFR siRNA-HER3 aptamer chimera.

This construction enables the EGFR component to reach its target within HER2- and HER3-expressing cells. Compared to individual components, the chimera is large enough to avoid renal depletion, resulting in a prolonged circulation time and increased efficiency.

The newly crafted molecule is non-toxic, simple to produce, and cost-effective compared to the production of alternate treatment strategies, such as antibodies and small molecule inhibitors.

Liu's ongoing studies are testing the ability of the three-in-one chimera to treat breast cancers that are resistant to Herceptin, a drug that targets HER2.

This work is being done in collaboration with Dr. Hasan Korkaya who has developed drug-resistant cell lines, and with breast cancer clinicians.

"We need to prove that this molecule will work on Herceptin-resistant breast cancer patients," Liu said.

Since other cancers, such as lung and head and neck, proliferate due to HER family over-expression, Liu anticipates that the chimera's utility will not be limited to breast cancers alone.

The findings from this study are published in the publication Molecular Therapy: Nucleic Acids.

A A
       SCI&TECH
Next Article: Here is how you can travel smart using these apps!
 
 
SCI&TECH HEADLINES
PMSing? Could be because of alcohol!  
Social media firms given a week to better protect kids  
The stronger you are, the healthier your brain is  
NASA may soon identify 2,400 alien planets  
What triggers depression among adults?  
Turn your hobbies into part-time job opportunities with these apps  
Apple launches special RED Edition for iPhone 8, 8 Plus  
Humanity’s first flight to Sun to launch in July: NASA  
This World Health Day, let's focus on eye health  
Are babies being introduced to solid food too soon?  
New organ found in human body, could help understand spread of cancer  
Audio-enabled autoplay videos will soon be blocked on Google Chrome  
China hospital to employ AI to address doctor shortage  
A new ray of hope for breast cancer patients!  
Here is how you can travel smart using these apps!  
5 most important aspects of our lives driven by technology  
This telehealth program offers hope for diabetics  
New habitable planet found near our solar system  
Going light with the new Light Phone 2  
What will happen to this beautiful blue planet?  
Liver cancer: New method identifies splicing biomarkers  
Astronomers reveal secrets of most distant supernova ever detected  
Ensuring sexual, reproductive health for overall well-being  
WeChat gets popular in Bhutan: report  
Celebrate love this Valentine's Day with Google Pixel 2  
 
Do you agree with setting age limits for giving death penalty to rapists?
yes
 
no
 
no opinion
 
 
 
Home Kerala India World Business Sports Sci&Tech Education Automobile CityNews Movies Environment Letters 
© Copyright keralakaumudi Online 2011  |  Reproduction in whole or in part without written permission is prohibited.
Head Office Address: Kaumudi Buildings, Pettah P.O, Trivandrum - 695024, India.
Online queries talk to Deepu Sasidharan, + 91 98472 38959 or Email deepu[at]kaumudi.com
Customer Service -Advertisement Disclaimer Statement   |  Copyright Policy